X

Trial Profile

A Randomized, Double-blind, Placebo-controlled Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Study of Administrating Single Ascending Dose of HMS5552 in Healthy Adult Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Jul 2015

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dorzagliatin (Primary)
Indications Type 2 diabetes mellitus
Focus Adverse reactions
Sponsors Hua Medicine

Most Recent Events

09 Jun 2015 Results of pooled analysis of two phase I trials presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
19 Mar 2014 Results were reported in a Hua Medicine media release.
19 Mar 2014 Results will be presented at the American Diabetes Association Conference according to a Hua Medicine media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com